🚚 Free Tracked 24 on all pens · other orders free over £50, otherwise £5.99 🖊️ Peptide Pens → 🖊️ Retatrutide Pens: 20mg £124.99 · 40mg £159.99 → 🎬 View Peptide Videos → 🔬 New: Senolytics & Longevity Research. Explore the science → 👤 Members save 10% on eligible products. Join free → 🚚 Free Tracked 24 on all pens · other orders free over £50, otherwise £5.99 🖊️ Peptide Pens → 🖊️ Retatrutide Pens: 20mg £124.99 · 40mg £159.99 → 🎬 View Peptide Videos → 🔬 New: Senolytics & Longevity Research. Explore the science → 👤 Members save 10% on eligible products. Join free → 🚚 Free Tracked 24 on all pens · other orders free over £50, otherwise £5.99 🖊️ Peptide Pens → 🖊️ Retatrutide Pens: 20mg £124.99 · 40mg £159.99 → 🎬 View Peptide Videos → 🔬 New: Senolytics & Longevity Research. Explore the science → 👤 Members save 10% on eligible products. Join free →

Tirzepatide

For In-Vitro Laboratory Research Use Only • Not for Human or Veterinary Use

Tirzepatide (LY3298176) is a synthetic 39-amino-acid linear peptide and dual GIP/GLP-1 receptor agonist studied in incretin and intracellular receptor-signalling research. Supplied as a lyophilised powder for in-vitro laboratory research use only, with batch verification and Certificate of Analysis (COA) documentation.

£15.99 – £155.99 / vialFrom £13.59 / vial (15% Multi-Vial Savings)

🧪 MULTI-VIAL RESEARCH SAVINGS Buy 2 Save 10% · Buy 3+ Save 15%
1 Vial Standard £15.99 / vial
Buy 2 Vials Save 10% £14.39 / vial
Buy 3+ Vials Save 15% £13.59 / vial
Mix & match vials — 10% off 2 vials and 15% off 3+ vials auto-applies in your basket + Free Tracked 24 on all pens · other orders free over £50, otherwise £5.99.
💧 Reconstitution Bundle: add 10ml Bacteriostatic Water (£5.99) with any lyophilised peptide — FREE on orders over £100.
💧 + Add 10ml BAC Water (£5.99 / Free £100+)

Larger sizes (80mg, 100mg, 120mg) are available on request — contact us.

Ways to pay. You place the order first, then pay by a secure payment link (all major credit and debit cards including Visa, Mastercard and American Express, Apple Pay, Google Pay, PayPal including Pay in 3, or a Zilch virtual card) or by UK bank transfer.

FOR IN-VITRO LABORATORY RESEARCH USE ONLY — NOT FOR HUMAN OR VETERINARY USE

These products are research chemicals. They are not medicines, food, or supplements. They have not been evaluated by the MHRA, FDA, or any other regulatory body. Not intended to diagnose, treat, cure, or prevent any disease. All descriptions are for reference and research documentation purposes only. By purchasing, you confirm you are aged 18+ and using these products exclusively for in vitro laboratory research.

About Tirzepatide

Tirzepatide (development code LY3298176) is a synthetic 39-amino-acid peptide modified with a C20 fatty diacid side chain. It acts as an agonist at two incretin hormone receptors: the glucose-dependent insulinotropic polypeptide (GIP) receptor and the glucagon-like peptide-1 (GLP-1) receptor. It has the molecular formula C225H348N48O68 and a molecular weight of approximately 4813.5 g/mol.

Tirzepatide is also the active ingredient in licensed prescription medicines. The product sold here is a research compound for laboratory use only. It is not a medicine and is not for human use.

Related research compounds: Semaglutide (GLP-1 receptor), Retatrutide (GIP, GLP-1 and glucagon receptors) and Cagrilintide (an amylin analogue).

Areas of research

Tirzepatide is one of the most extensively studied dual-receptor peptides. Published research includes:

  • pharmacology studies in cells describing how it activates the GIP and GLP-1 receptors differently, sometimes described as “imbalanced” and “biased” agonism [1]
  • structural studies of how it binds to and activates the GIP and GLP-1 receptors [2, 3]
  • cell and mouse studies of how it acts on adipocyte nutrient metabolism through the GIP receptor [4]

These studies relate to tirzepatide as a pharmaceutical substance studied under controlled conditions. They are cited here for scientific background only.

Product specifications

Form Lyophilised (freeze-dried) powder in a sealed vial
Sizes 2mg, 5mg, 10mg, 15mg, 20mg, 30mg, 40mg, 50mg, 60mg
Structure 39-amino-acid peptide with a C20 fatty diacid side chain
Molecular formula C225H348N48O68
Molecular weight approx. 4813.5 g/mol
Purity Where your size has no COA of its own, the COA shown is for another batch size. Current COAs for the 10mg, 20mg, 30mg, 40mg and 60mg sizes report HPLC purity above 99.5%.

Storage and handling

Storage & Handling — Corex Vitality™ research vials

  • As supplied: freeze-dried (lyophilised) powder in a sealed vial. Room-temperature transit is normal for dry peptides.
  • Longer storage: keep the vial tightly closed in a freezer at −20 °C or colder, dry and away from light. Colder is better for long archives.
  • Short-term: a laboratory fridge (2–8 °C) is fine for vials you plan to open soon.
  • Before opening: let the closed vial warm to room temperature, ideally in a desiccator, so moisture does not condense on the powder. Work quickly and reseal tightly; absorbed moisture lowers the real peptide content.
  • Dissolving: choose a solvent based on the sequence (see the compound note below) and test a small portion first. Swirl gently; brief sonication in a water bath can help. Do not heat.
  • Once in solution: make up only what you need. Split any solution you keep into single-use aliquots, freeze at −20 °C or colder and thaw each aliquot only once. Peptides keep far less well in solution than as dry powder.
  • Safety: handle in a suitable laboratory with appropriate PPE, following your institution’s safety procedures, and avoid breathing the powder. Keep out of reach of children.

Compound note: Oxidation-sensitive: lipidated, overall acidic peptide containing tryptophan. If slow in water, a neutral-to-slightly-basic buffer (e.g. PBS up to about 1 mg/mL, or a trace of dilute aqueous ammonia then dilution) is the usual route. Protect from light; degassed solvent preferred.

For in-vitro laboratory research use only. Not for human or veterinary use. General guidance paraphrased from Bachem: Handling and Storage Guidelines for Peptides and Peptide Solubility.

Quality and testing

Tirzepatide batches we sell have a published third-party HPLC Certificate of Analysis. On Lingda reports the Client is the manufacturer/supplier; we publish the file exactly as issued. COAs have been issued for the 10mg, 20mg, 30mg, 40mg and 60mg batches; for other sizes, the COA shown is for one of those batches of the same compound. You can also browse every published certificate on our COA and verification page.

Research use only

For in-vitro laboratory research use only. Not for human or veterinary use. These products are research chemicals. They are not medicines, food, or supplements. They have not been evaluated by the MHRA, FDA, or any other regulatory body. Not intended to diagnose, treat, cure, or prevent any disease. All descriptions are for reference and research documentation purposes only. By purchasing, you confirm you are aged 18+ and using these products exclusively for in vitro laboratory research.

Related reading

References

  1. Willard FS, et al. Tirzepatide is an imbalanced and biased dual GIP and GLP-1 receptor agonist. JCI Insight. 2020. PubMed 32730231
  2. Zhao F, et al. Structural insights into multiplexed pharmacological actions of tirzepatide and peptide 20 at the GIP, GLP-1 or glucagon receptors. Nat Commun. 2022. PubMed 35217653
  3. Sun B, et al. Structural determinants of dual incretin receptor agonism by tirzepatide. Proc Natl Acad Sci U S A. 2022. PubMed 35333651
  4. Regmi A, et al. Tirzepatide modulates the regulation of adipocyte nutrient metabolism through long-acting activation of the GIP receptor. Cell Metab. 2024. PubMed 38878772

Additional information

Size

2mg, 5mg, 10mg, 15mg, 20mg, 30mg, 40mg, 50mg, 60mg

Reviews

There are no reviews yet.

Only logged in customers who have purchased this product may leave a review.

Cover of the free guide: How to read a COA

Free guide

How to read a COA

Get it by email, plus our research updates. No spam, unsubscribe any time.

We will email you to confirm first, then send the guide. We use your name and email only to send you these emails. Privacy policy. For laboratory research use only.

Listed on PepmarketVerified on PeptideReview
🎬 Scientific Explainer Video · What It Is For & How It Works

Tirzepatide — Laboratory Mechanism & Research Overview

⬇ Download Video (MP4) All Peptide Videos →
🔬 What Is This Peptide Researched For?
  • Examining synergistic GIP-receptor and GLP-1-receptor dual co-agonism in islet & adipose assays
  • Investigating biased cAMP signalling vs beta-arrestin recruitment at the GLP-1 receptor
  • Studying insulin sensitivity, adipocyte lipid buffering & incretin receptor desensitisation
⚙️ How Does It Work? (Mechanism of Action)
1. Imbalanced Dual GPCR Binding: Binds GIPR with native affinity and GLP-1R with biased cAMP-favouring affinity.
2. Low Beta-Arrestin Recruitment: Minimises receptor internalisation while sustaining intracellular cAMP elevation.
3. Synergistic Incretin Signalling: Enhances beta-cell GSIS and adipocyte metabolic gene transcription in pre-clinical models.
📚 Peer-Reviewed Literature · PubMed Indexed

Published Research — Tirzepatide (LY3298176)

NCBI PubMed Database ↗ Verify Batch COAs →
  1. [1] Willard FS et al. · JCI Insight (2020)

    In-vitro receptor signalling and occupancy study demonstrating full GIPR agonism and biased GLP-1R signalling favouring cyclic AMP (cAMP) generation over β-arrestin recruitment and receptor internalisation.

    PMID: 32730231 ↗ DOI: 10.1172/jci.insight.140532 ↗
  2. [2] Zhao F et al. · Nat Commun (2022)

    Cryo-electron microscopy structure determination of tirzepatide bound to GIPR and GLP-1R, defining the near-atomic extracellular and transmembrane receptor-ligand interactions governing dual incretin agonism.

    PMID: 35217653 ↗ DOI: 10.1038/s41467-022-28683-0 ↗
  3. [3] Sun B et al. · Proc Natl Acad Sci U S A (2022)

    Cryo-EM and molecular dynamics analysis demonstrating how the C20 fatty-diacid acylation moiety and chimeric peptide sequence govern GIPR and GLP-1R receptor activation and reduced GLP-1R desensitisation.

    PMID: 35333651 ↗ DOI: 10.1073/pnas.2116506119 ↗
  4. [4] Regmi A et al. · Cell Metab (2024)

    Cellular and murine receptor-signalling study showing that long-acting GIPR agonism modulates intracellular insulin-receptor cascade cooperativity, glucose transport, glycerol conversion, and lipolytic flux in cultured adipocytes.

    PMID: 38878772 ↗ DOI: 10.1016/j.cmet.2024.05.010 ↗

References are provided for scientific context only. All Corex Vitality™ compounds are supplied strictly for in-vitro laboratory research use (RUO).